Karine ROSSIGNOL
CEO and co-founder of Smart Immune
Smart Immune
Paris, France
Before co-founding Smart Immune in 2017, I was the CEO of the French Foundation for Hearing and the co-secretary general of the Imagine Institute for 10 years.
My organisation
About me
Karine has a strong track record of 30 years in industry and biomedical research institutes. As a Doctor of Pharmacy and a HEC Business School graduate, she brings extensive managing experience in the public and private sectors. Before co-founding Smart Immune, she was the CEO of the French Foundation for Hearing for 3 years and the co-secretary general of the Imagine Institute of Genetic Diseases for 10 years, where she structured, developed, and ensured fundraising for the institute. She also has 15 years of experience at LVMH, L’Oréal, and Chanel where she deepened her international marketing expertise before earning a master’s degree in genetics.
My organisation
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T cell progenitor therapy platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The company aims to radically improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is already in Phase I/II clinical trials, in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The Company is headquartered in Paris, France, at Paris Biotech Santé.
Skills
- biotechnology
- Business
- Fundraising
- Strategy
- pharmaceutical industry
- large-scale operations
- Management
Interests
- cancer
- Innnovation
- cell therapy
- thymus
- CAR T cells
- Investment
- T cells
- biotechnology
- partnerships
Additional questions
Interested in HR networking ?
HiringSpeaker sessions (1)
Monday, 5 February 2024
18:00 - 18:40